Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between the ages of 18 and 75 (inclusive)
- People whose general physical health and ability to carry out daily activities falls within a certain functional range, as assessed by a doctor (confirm with trial site)
- People who have been diagnosed with locally advanced or metastatic breast cancer, confirmed through laboratory testing of tissue samples
- People who have previously received one or two rounds of hormone-based cancer treatment
- People whose life expectancy is estimated to be more than 6 months
- People whose organs (such as liver and kidneys) are functioning at a level that meets the trial's requirements (confirm with trial site)
- People who are willing to take part voluntarily, are able to follow the trial's visit schedule and procedures, and have signed a consent form after being informed about the study
Who may not be able to join:
- People whose cancer is progressing quickly in a way that a doctor determines makes hormone-based treatment unsuitable or unlikely to be tolerated
- People with a history of serious heart or blood vessel disease
- People experiencing cancer-related pain that cannot be adequately controlled, as determined by a doctor
- People who have had a serious infection within the 4 weeks before starting the trial treatment
- People with significant abnormalities of the uterine lining, as identified by a doctor
- People with active hepatitis that has not been treated
- People known to be allergic to any components of the study drug HRS-8080
- Women who are pregnant, breastfeeding, or planning to become pregnant during the study period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-0518-82342973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression free survival (PFS) evaluated by the blinded independent central review (BICR).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.